00000000nam 2200000zi 4500
0019.902455
003CaOODSP
00520221107175951
006m     o  d f      
007cr bn|||||||||
008210811t19851986quc     o    f000 0 eng d
020 |z0662541944
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---|an-us---
0861 |aRG48-1/1-1986E-PDF|zRG48-1/1-1986
24500|aU.S./Canada cost comparisons / |cPolicy Analysis and Liaison Branch, Bureau of Policy Coordination, Consumer and Corporate Affairs Canada.
264 1|a[Hull, Quebec] : |bConsumer and Corporate Affairs Canada, |c1985.
264 4|c©1986
300 |a1 online resource (1 volume (various pagings))
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |a"January 1985."
500 |a"Background study / Commission of Inquiry on the Pharmaceutical Industry"--Cover.
500 |aDigitized edition from print [produced by Innovation, Science and Economic Development Canada].
500 |aIssued also in French under title: Comparaison des coûts Canada/États-Unis.
5050 |a1983 drug store and hospital drug purchases : a comparison of Canada and the United States / Tom Brogan and Guy Roberge -- Drug cost differential between Canada and the U.S.A. / Tom Brogan, Mario Deschamps, Guy Roberge (May 1983) -- A comparison of pharmacy drug costs in Canada and the United States for selected years / Tom Brogan, Guy Roberge, Bernard Philie.
520 |a"This study estimates the impact of compulsory licensing on the costs of drugs purchased by drug stores and hospitals in 1983. The estimate is based on a comparison of expenditures for specific drugs purchased in the United States and Canada"--Introduction.
650 0|aDrugs|xPrices|zCanada.
650 0|aDrugs|xPrices|zUnited States.
7101 |aCanada. |bConsumer and Corporate Affairs Canada. |bPolicy Analysis and Liaison Branch, |eissuing body.
7101 |aCanada. |bCommission of Inquiry on the Pharmaceutical Industry, |eissuing body.
77508|tComparaison des coûts Canada/États-Unis / |w(CaOODSP)9.902468
85640|qPDF|s1.56 MB|uhttps://publications.gc.ca/collections/collection_2021/isde-ised/RG48-1-1-1986-eng.pdf
986 |a192 25163 B 86-05